Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolaevulinic acid photodynamic therapy

Photodermatology Photoimmunology and Photomedicine

Volumn 21, Issue 6, 2005, Pages 326-332

  Fransson, Jessica ^a   Ros, Anne Marie ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ALA PDT; Neovascularization; Psoriasis

Indexed keywords

AMINOLEVULINIC ACID; ANALGESIC AGENT; BLOOD CLOTTING FACTOR 8; CYTOKERATIN 16; EMLA; ENDOGLIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FILAGGRIN; INVOLUCRIN; LIDOCAINE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; MICROVASCULATURE; PAIN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SCORING SYSTEM; SKIN BIOPSY; SKIN CELL; ULTRAVIOLET B RADIATION; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; EPIDERMIS; EVALUATION STUDIES; EVALUATION STUDIES AS TOPIC; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PSORIASIS;

EID: 29444447145     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2005.00182.x     Document Type: Article

References (26)

1. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: principles and present clinical experience. J Photochem Photobiol B 1990; 6: 143-148.
2. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol 1998; 134: 207-214.
3. Lang K, Lehmann P, Bolsen K, Ruzicka T, Fritsch C. Aminolevulinic acid: pharmacological profile and clinical indication. Expert Opin Invest Drugs 2001; 10: 1139-1156.
4. Boehncke W-H, Sterry W, Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 1994; 343: 801.
5. Collins P, Robinson DJ, Stringer MR, Stables GI, Sheehan-Dare RA. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 137: 743-749.
6. Robinson DJ, Collins P, Stringer MR, et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol 1999; 79: 451-455.
7. Dawe RS, Cameron H, Yule S, Man I, Ibbotson SH, Ferguson J. UV-B phototherapy clears psoriasis through local effects. Arch Dermatol 2002; 138: 1071-1076.
8. Fijan S, Höningsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol 1995; 133: 282-288.
9. Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol 1995; 133: 501-511.
10. Castelijns FM, Gerritsen M-JP, van Erp PEJ, van de Kerkhof PCM. Immunohistochemical assessment of keratin 16 on paraffin-embedded sections of normal and hyperproliferative skin: monoclonal antibodies Ks8.12 and LL025 in a comparative study. Arch Dermatol Res 1999; 291: 59-63.
11. Kanitakis J, Ramirez-Bosca A, Reano A, Viac J, Roche P, Thivolet J. Filaggrin expression in normal and pathological skin. Virch Arch A Pathol Anat Histopathol 1988; 412: 375-382.
12. 125I] epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol 1986; 86: 260-265.
13. Nanney LB, McKanna JA, Stoscheck CM, Carpenter G, King LE. Visualisation of epidermal growth factor receptors in human epidermis. J Invest Dermatol 1984; 82: 165-169.
14. van der Vleuten CJM, de Jong EMGJ, van de Kerkhof PCM. Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol. Arch Dermatol Res 1996; 288: 366-372.
15. Lowe PM, Lee M-L, Jackson CJ, To S-ST, Cooper AJ, Schrieber L. The endothelium in psoriasis. Br J Dermatol 1995; 132: 497-505.
16. Benstead K, Moore JV. Quantitative histological changes in murine tail skin following photodynamic therapy. Br J Cancer 1989; 59: 503-509.
17. Wang I, Andersson-Engels S, Nilsson GE, Wårdell K, Svanberg K. Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser Doppler perfusion imaging. Br J Dermatol 1997; 136: 184-189.
18. Statius van Eps RG, Adili F, Watkins MT, Anderson RR, LaMuraglia GM. Photodynamic therapy of extracellular matrix stimulates endothelial cell growth by inactivation of matrix-associated transforming growth factor-β. Lab Invest 1997; 76: 257-266.
19. Heimark RL, Twardzik DR, Schwartz SM. Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 1986; 233: 1078-1080.
20. Boehncke W-H, König K, Kaufmann R, Scheffold W, Prummer O, Sterry W. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch Dermatol Res 1994; 286: 300-303.
21. Ros A-M, Garden JM, Bakus AD, Hedblad M-A. Psoriasis response to the pulsed dye laser. Lasers Surg Med 1996; 19: 331-335.
22. Zelickson BD, Mehregan DA, Wendelschfer-Crabb G, et al. Clinical and histologic evaluation of psoriatic plaques treated with a flashlamp, pulsed dye laser. J Am Acad Dermatol 1996; 35: 64-68.
23. Hern S, Allen MH, Sousa AR, et al. Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries. Br J Dermatol 2001; 145: 45-53.
24. Braverman IM, Sibley J. Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol 1982; 78: 12-17.
25. Braverman IM, Sibley J. The response of psoriatic epidermis and microvessels to treatment with topical steroids and oral methotrexate. J Invest Dermatol 1985; 85: 584-586.
26. Westphal JR, Willems HW, Schalkwijk CJM, Ruiter DJ, de Waal RMW. A new 180-kDa dermal endothelial cell activation antigen: in vitro and in situ characteristics. J Invest Dermatol 1993; 100: 27-34.